BrettMCarlsonMD

PubMed

• Retinoblastoma Binding Protein 4 Modulates Temozolomide Sensitivity in Glioblastoma by Regulating DNA Repair Proteins.
  Kitange, G. J.,Mladek, A. C.,Schroeder, M. A.,Pokorny, J. C.,Carlson, B. L.,Zhang, Y.,Nair, A. A.,Lee, J. H.,Yan, H.,Decker, P. A.,Zhang, Z.,Sarkaria, J. N.> ;Cell Rep. 1900 Jan 01
• Factors Influencing the Central Nervous System Distribution of a Novel Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitor GSK2126458: Implications for O...
  Vaidhyanathan, S.,Wilken-Resman, B.,Ma, D. J.,Parrish, K. E.,Mittapalli, R. K.,Carlson, B. L.,Sarkaria, J. N.,Elmquist, W. F.> ;J. Pharmacol. Exp. Ther.. 2015 Nov 26
• 48 citations
  Src family kinases differentially influence glioma growth and motility.
  Laura J. Lewis-Tuffin, Ryan W. Feathers, Priya Hari, Nisha Durand, Zhimin Li, Fausto J. Rodriguez, Katie Bakken, Brett L. Carlson, Mark A. Schroeder, Jann N. Sarkaria,...> ;Molecular Oncology. 2015 Nov 1
• The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood-Brain Barrier in Glioblastoma.
  Pokorny, J. L.,Calligaris, D.,Gupta, S. K.,Iyekegbe, D. O.,Mueller, D.,Bakken, K. K.,Carlson, B. L.,Schroeder, M. A.,Evans, D. L.,Lou, Z.,Decker, P. A.,Eckel-Passow, J...> ;Clin. Cancer Res.. 2015 Jan 23
• Join now to see all